Sign up to save your podcasts
Or
Share Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
CME credits: 0.25
Valid until: 15-07-2023
Claim your CME credit at https://reachmd.com/programs/cme/personalizing-nsclc-the-optimal-applicability-of-ngs-and-liquid-biopsy/13834/
There are new targeted therapies that are now approved for the treatment of advanced non-small cell lung cancer. Dr. Mark Socinski & Dr. Marie Suga discuss evolving diagnostic approaches and best practices for selecting the right therapy for patients with NSCLC.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 15-07-2023
Claim your CME credit at https://reachmd.com/programs/cme/personalizing-nsclc-the-optimal-applicability-of-ngs-and-liquid-biopsy/13834/
There are new targeted therapies that are now approved for the treatment of advanced non-small cell lung cancer. Dr. Mark Socinski & Dr. Marie Suga discuss evolving diagnostic approaches and best practices for selecting the right therapy for patients with NSCLC.
=